| DAVITA |
DAVITA |
92%
|
Rockwell currently serves 294 customers, highlighted by all five of the leading dialysis providers in the United States, including Fresenius and DaVita. |
| FRESENIUS |
FRESENIUS |
92%
|
Rockwell currently serves 294 customers, highlighted by all five of the leading dialysis providers in the United States, including Fresenius and DaVita. |
| FRESENIUS-MEDICAL-CARE-NORTH-AMERICA |
FRESENIUS-MEDICAL-CARE-NORTH-AMERICA |
92%
|
For the three months ended March 31, 2026, revenues from sales to two customers, Fresenius Medical Care North America ("Fresenius") and Nipro Medical Corporation, a subsidiary of Nipro Corporation Ja… |
| INNOVATIVE-RENAL-CARE |
INNOVATIVE-RENAL-CARE |
92%
|
In July 2025, Rockwell Medical signed a multi-year product purchase agreement with Innovative Renal Care, one of the largest dialysis service providers in the United States. |
| EVOQUA-WATER-TECHNOLOGIES |
EVOQUA-WATER-TECHNOLOGIES |
90%
|
The final Evoqua payment was made in April 2026. |
| ONE-OF-THE-LARGEST-DIALYSIS-PROVIDERS-IN-THE-UNI |
ONE-OF-THE-LARGEST-DIALYSIS-PROVIDERS-IN-THE-UNI |
90%
|
In December 2025, we extended our Amended and Restated Products Purchase Agreement (the "Amended Agreement") dated September 18, 2023 with one of the largest dialysis providers in the United States t… |
| EVOQUA-WATER-TECHNOLOGIES-LLC |
EVOQUA-WATER-TECHNOLOGIES-LLC |
85%
|
mpact this ASU will have on the consolidated financial statements and footnote disclosures. Note 4. Intangible Assets and Deferred Consideration Intangible Assets Our customer relationship intangible… |
| DROGSAN-PHARMACEUTICALS |
DROGSAN-PHARMACEUTICALS |
80%
|
Three months ended March 31, 2025 includes $0.3 million of deferred revenue related to the distribution and license agreements with Sun Pharmaceuticals Industries Ltd., Jeil Pharmaceutical Co., Ltd. … |
| SUN-PHARMACEUTICALS-INDUSTRIES-LTD |
SUN-PHARMACEUTICALS-INDUSTRIES-LTD |
80%
|
Three months ended March 31, 2025 includes $0.3 million of deferred revenue related to the distribution and license agreements with Sun Pharmaceuticals Industries Ltd., Jeil Pharmaceutical Co., Ltd. … |
| ABOUT-ROCKWELL-MEDICAL-ROCKWELL-MEDICAL-INC |
ABOUT-ROCKWELL-MEDICAL-ROCKWELL-MEDICAL-INC |
62%
|
sures, including net loss and other GAAP results. About Rockwell Medical Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a p… |
